ELII: Preclinical Development of Novel Reickettsiosis Therapeutics Targeting EPAC1

Project: Other project

StatusFinished
Effective start/end date4/10/143/31/19

Funding

  • UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON: $382,207.00